EUVIMEDEUVIMED entdecken
Crossref

A DNA/Upconversion Nanoparticle Complex Enables Controlled Co‐Delivery of CRISPR‐Cas9 and Photodynamic Agents for Synergistic Cancer Therapy

Nachuan Song, Xiaoting Fan, Xiaocui Guo, Jianpu Tang, Hongjin Li, Ruoyu Tao, Fengqin Li, Junru Li, Dayong Yang, Chi Yao, Peifeng Liu iD

Advanced Materials · 2024-04 · 36 (15)

DOI: 10.1002/adma.202309534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 15.01.2024. Verfasst von Nachuan Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Frontiers Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering (MOE), School of Chemical Engineering and Technology, Tianji…. Hauptthemen laut MEDLINE: Photochemotherapy, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovative Research Team of High-level Local Universities in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) depends on the light‐irradiated exciting of photosensitizer (PS) to generate reactive oxygen species (ROS), which faces challenges and limitations in hypoxia and antioxidant response of cancer cells, and limited tissue‐penetration of light. Herein, a multifunctional DNA/upconversion nanoparticles (UCNPs) complex is developed which enables controlled co‐delivery of CRISPR‐Cas9, hemin, and protoporphyrin (PP) for synergistic PDT. An ultralong single‐stranded DNA (ssDNA) is prepared via rolling circle amplification (RCA), which contains recognition sequences of single guide RNA (sgRNA) for loading Cas9 ribonucleoprotein (RNP), G‐quadruplex sequences for loading hemin and PP, and linker sequences for combining UCNP. Cas9 RNP cleaves the antioxidant regulator nuclear factor E2‐related factor 2 (Nrf2), improving the sensitivity of cancer cells to ROS, and enhancing the synergistic PDT effect. The G‐quadruplex/hemin DNAzyme mimicks horseradish peroxidase (HRP) to catalyze the endogenous H 2 O 2 to O 2 , overcoming hypoxia condition in tumors. The introduced UCNP converts NIR irradiation with deep tissue penetration to light with shorter wavelength, exciting PP to transform the abundant O 2 to 1 O 2 . The integration of gene editing and PDT allows substantial accumulation of 1 O 2 in cancer cells for enhanced cell apoptosis, and this synergistic PDT has shown remarkable therapeutic efficacy in a breast cancer mouse model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyNanoparticlesNeoplasmsMiceAnimalsCRISPR-Cas SystemsReactive Oxygen SpeciesAntioxidantsHeminHydrogen PeroxideRNA, Guide, CRISPR-Cas SystemsPhotosensitizing AgentsHypoxiaCell Line, Tumor

Stichwörter der Autor:innen

CRISPR‐Cas9DNA nanotechnologygene editingphotodynamic therapyupconversion nanoparticle

Substanzen

Reactive Oxygen SpeciesAntioxidantsHeminHydrogen PeroxideRNA, Guide, CRISPR-Cas SystemsPhotosensitizing Agents

Autor:innen und Institutionen

  • Frontiers Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering (MOE), School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, P. R. China.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, P. R. China.
  • Department of Chemistry, State Key Laboratory of Molecular Engineering of Polymers, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, College of Chemistry and Materials, Fudan University, Shanghai…
  • CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, P. R. China.

ORCID-Profile: Peifeng Liu

Förderung

  • National Natural Science Foundation of China
  • Innovative Research Team of High-level Local Universities in Shanghai

Zitieren

APA

Song, N., Fan, X., Guo, X., Tang, J., Li, H., Tao, R., Li, F., Li, J., Yang, D., Yao, C., & Liu, P. (2024). A DNA/Upconversion Nanoparticle Complex Enables Controlled Co‐Delivery of CRISPR‐Cas9 and Photodynamic Agents for Synergistic Cancer Therapy. Advanced Materials, 36(15). https://doi.org/10.1002/adma.202309534

Vancouver

Song N, Fan X, Guo X, Tang J, Li H, Tao R, et al. A DNA/Upconversion Nanoparticle Complex Enables Controlled Co‐Delivery of CRISPR‐Cas9 and Photodynamic Agents for Synergistic Cancer Therapy. Advanced Materials. 2024;36(15). doi:10.1002/adma.202309534

BibTeX
@article{Song2024,
  author = {Song, Nachuan and Fan, Xiaoting and Guo, Xiaocui and Tang, Jianpu and Li, Hongjin and Tao, Ruoyu and Li, Fengqin and Li, Junru and Yang, Dayong and Yao, Chi and Liu, Peifeng},
  title = {A DNA/Upconversion Nanoparticle Complex Enables Controlled Co‐Delivery of CRISPR‐Cas9 and Photodynamic Agents for Synergistic Cancer Therapy},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {15},
  doi = {10.1002/adma.202309534}
}
Kostenlos starten →